Heart Rate and Oxygen Uptake Kinetics in Type 2 Diabetes Patients – A Pilot Study on the Influence of Cardiovascular Medication on Regulatory Processes

Abstract

The aim of this pilot study was to investigate whether there are differences in heart rate and oxygen uptake kinetics in type 2 diabetes patients, considering their cardiovascular medication. It was hypothesized that cardiovascular medication would affect heart rate and oxygen uptake kinetics and that this could be detected using a standardized exercise test. 18 subjects were tested for maximal oxygen uptake. Kinetics were measured in a single test session with standardized, randomized moderate-intensity work rate changes. Time series analysis was used to estimate kinetics. Greater maxima in cross-correlation functions indicate faster kinetics. 6 patients did not take any cardiovascular medication, 6 subjects took peripherally acting medication and 6 patients were treated with centrally acting medication. Maximum oxygen uptake was not significantly different between groups. Significant main effects were identified regarding differences in muscular oxygen uptake kinetics and heart rate kinetics. Muscular oxygen uptake kinetics were significantly faster than heart rate kinetics in the group with no cardiovascular medication (maximum in cross-correlation function of muscular oxygen uptake vs. heart rate; 0.32±0.08 vs. 0.25±0.06; p=0.001) and in the group taking peripherally acting medication (0.34±0.05 vs. 0.28±0.05; p=0.009) but not in the patients taking centrally acting medication (0.28±0.05 vs. 0.30±0.07; n.s.). It can be concluded that regulatory processes for the achievement of a similar maximal oxygen uptake are different between the groups. The used standardized test provided plausible results for heart rate and oxygen uptake kinetics in a single measurement session in this patient group.

Key words

diabetes - hypertension - obesity

• References

• 1 Moss SE, Klein R, Klein B. Cause-specific mortality in a population-based study of diabetes. Am J Public Health 1991; 81: 1158-1162
• 2 Marks JB, Raskin P. Cardiovascular risk in diabetes – A brief review. J Diabetes Complications 2000; 14: 108-115
• 3 Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease an update. Hypertension 2001; 37: 1053-1059
• 4 Fischer H. Diabetes, Sport und Bewegung. Clin Res Cardiol 2011; Suppl 6: 6-9
• 5 American Diabetes Association (ADA). Position statement: treatment of hypertension in adults with diabetes. Diabetes Care 2002; 25: 199-201
• 6 Savoia C, Schiffrin EL. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci 2007; 112: 375-384
• 7 Chehade JM, Gladysz M, Mooradian AD. Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management. Drugs 2013; 73: 327-339
• 8 Sharma S, Jains S. Prevalence of obesity among type-2 diabetics. J Hum Ecol 2009; 25: 31-35
• 9 Petrella RJ, Cunningham DA, Paterson DH. Exercise gas transport determinants in elderly normotensive and hypertensive humans. Exp Physiol 1999; 84: 79-91
• 10 Taniguchi Y, Ueshima K, Chiba I. et al. A new method using pulmonary gas-exchange kinetics to evaluate efficacy of ß-blocking agents in patients with dilated cardiomyopathy. Chest 2003; 124: 954-961
• 11 Dayi SÜ, Terzi S, Akbulut T. et al. Effect of acute blood pressure reduction on oxygen uptake kinetics at the onset of exercise in hypertensive patients. Jpn Heart J 2004; 45: 799-805
• 12 Guazzi M, Arena R. The impact of pharmacotherapy on the cardiopulmonary exercise test response in patients with heart failure: A mini review. Curr Vasc Pharmacol 2009; 7: 557-569
• 13 Grassi B, Porcelli S, Salvadego D. et al. Slow V’O₂ kinetics during moderate moderate-intensity exercise as markers of lower metabolic stability and lower exercise tolerance. Eur J Appl Physiol 2011; 111: 345-355
• 14 Hoffmann U, Drescher U, Benson AP. et al. Skeletal muscle V’O₂ kinetics from cardio-pulmonary measurements: assessing distortions through O₂ transport by means of stochastic work-rate signals and circulatory modelling. Eur J Appl Physiol 2013; 113: 1745-1754
• 15 Sandrone G, Mortara A, Torzillo D. et al. Effects of Beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction. Am J Cardiol 1994; 74: 340-345
• 16 Bauer TA, Reusch JE, Levi M. et al. Skeletal muscle deoxygenation after the onset of moderate exercise suggests slowed microvascular blood flow kinetics in type 2 diabetes. Diabetes Care 2007; 30: 2880-2885
• 17 Mac Ananey O, Malone J, Warmington S. et al. Cardiac output is not related to the slowed O₂ uptake kinetics in type 2 diabetes. Med Sci Sports Exerc 2011; 43: 935-942
• 18 Regensteiner JG, Sippel JM, McFarling ET. et al. Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise. Med Sci Sports Exerc 1995; 27: 875-881
• 19 Regensteiner JG, Bauer TA, Reusch JE. et al. Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus. J Appl Physiol 1998; 85: 310-317
• 20 Wilkerson DP, Poole DC, Jones AM. et al. Older Type 2 diabetic males do not exhibit abnormal pulmonary oxygen uptake and muscle oxygen utilization dynamics during submaximal cycling exercise. Am J Physiol Regul Integr Comp Physiol 2011; 300: R685-R692
• 21 O’Connor E, Kiely C, O’Shea D. et al. Similar level of impairment in exercise performance and oxygen uptake kinetics in middle-aged men and women with type 2 diabetes. Am J Physiol Regul Integr Comp Physiol 2012; 303: R70-R76
• 22 O'Connor E, Green S, Kiely C. et al. Differential effects of age and type 2 diabetes on dynamic vs. peak response of pulmonary oxygen uptake during exercise. J Appl Physiol 2015; 118: 1031-1039
• 23 Beaver WL, Lamarra N, Wasserman K. Breath-by-breath measurement of true alveolar gas exchange. J Appl Physiol 1987; 51: 1662-1675
• 24 Kindermann W. Ergometrie-Empfehlungen für die ärztliche Praxis. Dtsch Z Sportmed 1987; 38: 245-269
• 25 Aitken JC, Thompson J. The respiratory V’CO₂/V’O₂ exchange ratio during maximum exercise and its use as a predictor of maximum oxygen uptake. Eur J Appl Physiol 1988; 57: 714-719
• 26 Meyer T. Der respiratorische Quotient (RQ). Dtsch Z Sportmed 2003; 54: 29-30
• 27 Lamarra N, Whipp BJ, Ward SA. et al. Effect of interbreath fluctuations on characterizing exercise gas exchange kinetics. J Appl Physiol 1987; 62: 2003-2012
• 28 Drescher U, Koschate J, Hoffmann U. Oxygen uptake and heart rate kinetics during dynamic upper and lower body exercise: an investigation by time-series analysis. Eur J Appl Physiol 2015; 115: 1665-1672
• 29 Koschate J, Drescher U, Baum K. et al. Muscular oxygen uptake kinetics in aged adults. Int J Sports Med 2016; 37: 516-524
• 30 How O-J, Aasum E, Severson DL. et al. Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 2006; 55: 466-473
• 31 Amaral N, Okonko DO. Metabolic abnormalities of the heart in type II diabetes. Diab Vasc Dis Res 2015; 12: 239-248
• 32 Fillmore N, Lopaschuk GD. Impact of fatty acid oxidation on cardiac efficiency. Heart Metab 2011; 53: 33-37
• 33 Hafstad AD, Nabeebaccus AA, Shah AM. Novel aspects of ROS signalling in heart failure. Basic Res Cardiol 2013; 108: 1-11
• 34 Brandenburg S, Reusch J, Bauer T. et al. Effects of exercise training on oxygen uptake kinetic responses in women with type 2 diabetes. Diabetes Care 1999; 22: 1640-1646